UNIVERSAL INSURANCE HLDG, INC.
UVEUniversal Insurance Holdings, Inc. (UVE) is a Florida-based insurance company specializing in the underwriting of personal property and casualty insurance, primarily focusing on residential property insurance in the United States. The company operates through subsidiaries to provide home, auto, and umbrella insurance products, serving primarily in Florida and other select markets.
Dividend History
Investors can expect a dividend payout of $0.13 per share, scheduled to be distributed in 4 days on December 12, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 12, 2025 | $0.13 | 2025-12-05 | 2025-12-05 |
| December 12, 2025 | $0.16 | 2025-12-05 | 2025-12-05 |
| August 8, 2025 | $0.16 | 2025-08-01 | 2025-08-01 |
| May 16, 2025 | $0.16 | 2025-05-09 | 2025-05-09 |
| March 14, 2025 | $0.16 | 2025-03-07 | 2025-03-07 |
Dividends Summary
- UNIVERSAL INSURANCE HLDG, INC. has issued 87 dividend payments over the past 18 years
- The most recent dividend was paid 122 days ago, on August 8, 2025
- The highest dividend payed out to investors during this period was $0.20 per share
- The average dividend paid during this period was $0.13 per share.
Company News
The article highlights three dividend-paying companies - Tenaris SA, Artisan Partners Asset Management, and Universal Insurance Holdings - that still offer time to capture their May distributions. The companies are analyzed based on their fundamentals, dividend trends, and price momentum.
The company's inaugural set of quarterly results for this year featured some metrics that could have been better.
Universal Insurance (UVE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday. Shares of Bioventus Inc. (NASDAQ: BVS) rose sharply during Tuesday’s session after the company reported better-than-expected quarterly financial results and issued FY24 net sales guidance above estimates. Bioventus posted adjusted earnings of 7 cents per...
